The FDA has recently declared a nationwide EpiPen shortage. EpiPen is a medication produced by the pharmaceutical company, Mylan. It delivers the life-saving drug, epinephrine, for treatment of severe allergic reactions. More recently, even the generic epinephrine auto-injector, Adrenaclick, has been added to the list of shortages.
A Recent Study Suggests Early Peanut Introduction has an Allergen Specific Effect and Does Not Prevent Development of Other Allergies
A study published this month in the Journal of Allergy and Clinical Immunology suggests that the protective properties of preventing peanut allergy with early peanut introduction does not extend to other allergic diseases.
There is good news for parents with infants between 16.5 and 33 pounds with a history of life threatening anaphylaxis. Kaleo, the pharmaceutical company behind the life-saving medication, Auvi Q, announced that a 0.1 mg dose for their epinephrine autoinjector will be available starting May 1, 2018.
Contact allergy is a delayed reaction that can causes rashes. Reactions can range in severity from mild redness to blistering of the skin. There are two types of contact dermatitis: irritant and allergic.
A New Study Suggests that Early Antibiotic and Antacid Use in Infants is Associated with Increased Development of Allergy
A study published in this month’s JAMA Pediatrics suggest that there is an association between use of acid suppressive medications and antibiotics early in infancy and the development of allergy.